Prevacus

About:

Prevacus is a drug development company working on the prevention and treatment of mild traumatic brain injury (mTBI) or concussion.

Website: http://prevacus.com

Top Investors: Florida Institute for the Commercialization of Florida Technology

Description:

Prevacus, Inc. is a drug development company working on prevention and treatment of mild traumatic brain injury (mTBI) or concussion. Every year 4-6 million people suffer from mTBIs many of which do not reach an emergency room and go unreported. Apart from analgesics for associated pain and anti-depressants, there are no approved pharmaceutical therapies for mTBI.

Total Funding Amount:

$1.66M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Tallahassee, Florida, United States

Founded Date:

2012-01-01

Contact Email:

jvan(AT)prevacus.com

Founders:

Jacob Vanlandingham

Number of Employees:

1-10

Last Funding Date:

2013-02-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai